Table 5.
Alternative cipro prescription n (%) | |||
---|---|---|---|
With bacteriological finding |
|
28 (58.3) |
|
|
P. aeruginosa |
|
6 |
|
|
Cystic fibrosis pulmonary infection |
3 |
|
|
Site of infection for with P. aeruginosa without CF# |
3 |
|
|
Oral cipro |
6 |
|
E. coli |
|
6 |
|
CNS ¶ |
|
5 |
|
K. pneumoniae |
|
3 |
|
MRSA £ |
|
2 |
|
S. marcescens |
|
2 |
|
Others * |
|
4 |
|
|
Oral cipro |
9 |
|
|
Intravenous cipro |
13 |
|
|
Site of infection for non P. aeruginosa$ |
22 |
Alternative by another active antibiotic |
28 |
||
Without bacteriological finding |
|
20 (41.7) |
|
Alternative by another antibiotic |
20 |
||
|
Site of infection for non bacteriologically documented infection & |
17 |
|
|
Empiric therapy for fever with current neutropenia |
3 |
|
|
|
Intravenous cipro |
13 |
|
|
Oral cipro |
7 |
Total | 48 (100) |
CNS = coagulase negative Staphylococcus, MRSA = Methicillin-resistant S. aureus.
¶ 5 CNSs were isolated from hemocultures, of which 2 had endocarditis, 1 catheter related bloodstream infection.
# 2 urinary infection and 1 operative site infection with P. aeruginosa.
£ One child with CF had MRSA pulmonary infection.
* E. cloacae, H. influenzae, M. catarrhalis, K. oxytoca, each.
$ 8 pulmonary, 3 urinary, 3 intra-abdominal, 2 bloodstream, 3 operative site infection and 1 endocarditis, catheter related infection, osteomyelitis each.
& 5 pulmonary, 3 meningitis, 2 mediastinitis, 2 BCGitis and intra-abdominal infection, endocarditis, post-trauma ocular infection, osteomyelitis, urinary each.